Works by Loprinzi, Charles L.

Results: 145
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Prophylactic tetracycline does not diminish the severity of epidermal growth factor receptor (EGFR) inhibitor-induced rash: results from the North Central Cancer Treatment Group (Supplementary N03CB).

    Published in:
    2011
    By:
    • Jatoi A;
    • Dakhil SR;
    • Sloan JA;
    • Kugler JW;
    • Rowland KM Jr;
    • Schaefer PL;
    • Novotny PJ;
    • Wender DB;
    • Gross HM;
    • Loprinzi CL;
    • Jatoi, Aminah;
    • Dakhil, Shaker R;
    • Sloan, Jeff A;
    • Kugler, John W;
    • Rowland, Kendrith M Jr;
    • Schaefer, Paul L;
    • Novotny, Paul J;
    • Wender, Donald B;
    • Gross, Howard M;
    • Loprinzi, Charles L
    Publication type:
    journal article
    10
    11
    12

    Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8.

    Published in:
    2010
    By:
    • Kearns AE;
    • Northfelt DW;
    • Dueck AC;
    • Atherton PJ;
    • Dakhil SR;
    • Rowland KM Jr;
    • Fuloria J;
    • Flynn PJ;
    • Dentchev T;
    • Loprinzi CL;
    • Kearns, Ann E;
    • Northfelt, Donald W;
    • Dueck, Amylou C;
    • Atherton, Pamela J;
    • Dakhil, Shaker R;
    • Rowland, Kendrith M Jr;
    • Fuloria, Jyotsna;
    • Flynn, Patrick J;
    • Dentchev, Todor;
    • Loprinzi, Charles L
    Publication type:
    journal article
    13

    Levetiracetam for the treatment of hot flashes: a phase II study.

    Published in:
    2008
    By:
    • Thompson S;
    • Bardia A;
    • Tan A;
    • Barton DL;
    • Kottschade L;
    • Sloan JA;
    • Christensen B;
    • Smith D;
    • Loprinzi CL;
    • Thompson, Susan;
    • Bardia, Aditya;
    • Tan, Angelina;
    • Barton, Debra L;
    • Kottschade, Lisa;
    • Sloan, Jeff A;
    • Christensen, Brad;
    • Smith, DeAnne;
    • Loprinzi, Charles L
    Publication type:
    journal article
    14
    15
    16
    17
    18

    5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial.

    Published in:
    Cancer (0008543X), 2015, v. 121, n. 15, p. 2537, doi. 10.1002/cncr.29327
    By:
    • Wagner‐Johnston, Nina D.;
    • Sloan, Jeff A.;
    • Liu, Heshan;
    • Kearns, Ann E.;
    • Hines, Stephanie L.;
    • Puttabasavaiah, Suneetha;
    • Dakhil, Shaker R.;
    • Lafky, Jacqueline M.;
    • Perez, Edith A.;
    • Loprinzi, Charles L.
    Publication type:
    Article
    19

    Phase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance).

    Published in:
    Cancer (0008543X), 2014, v. 120, n. 22, p. 3575, doi. 10.1002/cncr.28892
    By:
    • Barton, Debra L.;
    • Thanarajasingam, Gita;
    • Sloan, Jeff A.;
    • Diekmann, Brent;
    • Fuloria, Jyotsna;
    • Kottschade, Lisa A.;
    • Lyss, Alan P.;
    • Jaslowski, Anthony J.;
    • Mazurczak, Miroslaw A.;
    • Blair, Scott C.;
    • Terstriep, Shelby;
    • Loprinzi, Charles L.
    Publication type:
    Article
    20

    North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: A phase 3 randomized, double-blind, placebo-controlled study.

    Published in:
    Cancer (0008543X), 2014, v. 120, n. 12, p. 1890, doi. 10.1002/cncr.28654
    By:
    • Leal, Alexis D.;
    • Qin, Rui;
    • Atherton, Pamela J.;
    • Haluska, Paul;
    • Behrens, Robert J.;
    • Tiber, Charles H.;
    • Watanaboonyakhet, Patanit;
    • Weiss, Matthias;
    • Adams, Paul T.;
    • Dockter, Travis J.;
    • Loprinzi, Charles L.
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29

    The National Cancer Institute Clinical Trials Planning Meeting for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy.

    Published in:
    2019
    By:
    • Dorsey, Susan G;
    • Kleckner, Ian R;
    • Barton, Debra;
    • Mustian, Karen;
    • O'Mara, Ann;
    • Germain, Diane St.;
    • Cavaletti, Guido;
    • Danhauer, Suzanne C;
    • Hershman, Dawn L;
    • Hohmann, Andrea G;
    • Hoke, Ahmet;
    • Hopkins, Judith O;
    • Kelly, Katherine P;
    • Loprinzi, Charles L;
    • McLeod, Howard L;
    • Mohile, Supriya;
    • Paice, Judith;
    • Rowland, Julia H;
    • Salvemini, Daniela;
    • Segal, Rosalind A
    Publication type:
    journal article
    30
    31
    32
    33
    34
    35
    36
    37

    Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial.

    Published in:
    2017
    By:
    • Himelstein, Andrew L.;
    • Foster, Jared C.;
    • Khatcheressian, James L.;
    • Roberts, John D.;
    • Seisler, Drew K.;
    • Novotny, Paul J.;
    • Rui Qin;
    • Go, Ronald S.;
    • Grubbs, Stephen S.;
    • O’Connor, Tracey;
    • Velasco Jr., Mario R.;
    • Weckstein, Douglas;
    • O’Mara, Ann;
    • Loprinzi, Charles L.;
    • Shapiro, Charles L.;
    • Qin, Rui;
    • O'Connor, Tracey;
    • Velasco, Mario R Jr;
    • O'Mara, Ann
    Publication type:
    journal article
    38
    39
    40

    Evaluation of shark cartilage in patients with advanced cancerThis study was conducted as a collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic and was supported in part by Public Health Service grants CA‐25224, CA‐37404, CA‐35113, CA‐63849, CA‐63848, CA‐35195, CA‐35272, CA‐35269, CA‐35103, CA‐35101, CA‐60276, CA‐52352, CA‐37417, CA‐35448.Additional participating institutions include: CentraCare Clinic, St. Cloud, MN 56301 (Harold E. Windschitl, M.D.); Siouxland Hematology‐Oncology Associates, Sioux City, IA 51105 (Donald Wender, M.D.) Iowa Oncology Research Association CCOP, Des Moines, IA 50314 (Roscoe F. Morton, M.D.); Toledo Community Hospital Oncology Program (Paul L. Schaefer, M.D.); Medcenter One Health Systems, Bismarck, ND 58506 (Edward J. Wos, D.O.); Cedar Rapids Oncology Project CCOP, Cedar Rapids, IA 52403 (Martin Wiesenfeld, M.D.); Meritcare Hospital CCOP, Fargo, ND 58122 (Preston Steen, M.D.): A North Central Cancer Treatment Group trial

    Published in:
    Cancer (0008543X), 2005, v. 104, n. 1, p. 176, doi. 10.1002/cncr.21107
    By:
    • Charles L. Loprinzi;
    • Ralph Levitt;
    • Debra L. Barton;
    • Jeff A. Sloan;
    • Pam J. Atherton;
    • Denise J. Smith;
    • Shaker R. Dakhil;
    • Dennis F. Moore;
    • James E. Krook;
    • Kendrith M. Rowland;
    • Miroslaw A. Mazurczak;
    • Alan R. Berg;
    • George P. Kim
    Publication type:
    Article
    41
    42

    Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy.

    Published in:
    2014
    By:
    • Beutler, Andreas S;
    • Kulkarni, Amit A;
    • Kanwar, Rahul;
    • Klein, Christopher J;
    • Therneau, Terry M;
    • Qin, Rui;
    • Banck, Michaela S;
    • Boora, Ganesh K;
    • Ruddy, Kathryn J;
    • Wu, Yanhong;
    • Smalley, Regenia L;
    • Cunningham, Julie M;
    • Le-Lindqwister, Nguyet Anh;
    • Beyerlein, Peter;
    • Schroth, Gary P;
    • Windebank, Anthony J;
    • Züchner, Stephan;
    • Loprinzi, Charles L
    Publication type:
    journal article
    43

    Sequencing of Charcot- Marie- Tooth disease genes in a toxic polyneuropathy.

    Published in:
    Annals of Neurology, 2014, v. 76, n. 5, p. 727, doi. 10.1002/ana.24265
    By:
    • Beutler, Andreas S.;
    • Kulkarni, Amit A.;
    • Kanwar, Rahul;
    • Klein, Christopher J.;
    • Therneau, Terry M.;
    • Qin, Rui;
    • Banck, Michaela S.;
    • Boora, Ganesh K.;
    • Ruddy, Kathryn J.;
    • Wu, Yanhong;
    • Smalley, Regenia L.;
    • Cunningham, Julie M.;
    • Le‐Lindqwister, Nguyet Anh;
    • Beyerlein, Peter;
    • Schroth, Gary P.;
    • Windebank, Anthony J.;
    • Züchner, Stephan;
    • Loprinzi, Charles L.
    Publication type:
    Article
    44
    45
    46

    Randomized Controlled Trial to Evaluate Transdermal Testosterone in Female Cancer Survivors With Decreased Libido; North Central Cancer Treatment Group Protocol N02C3.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 9, p. 672, doi. 10.1093/jnci/djk149
    By:
    • Barton, Debra L.;
    • Wender, Donald B.;
    • Sloan, Jeff A.;
    • Dalton, Robert J.;
    • Balcueva, Ernie P.;
    • Atherton, Pamela J.;
    • Bernath Jr, Albert M.;
    • Dekrey, Wanda L.;
    • Larson, Tim;
    • Bearden Ill, James D.;
    • Carpenter, Paul C.;
    • Loprinzi, Charles L.
    Publication type:
    Article
    47
    48
    49
    50